Kei Endo

1.9k total citations
84 papers, 1.4k citations indexed

About

Kei Endo is a scholar working on Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kei Endo has authored 84 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 23 papers in Surgery and 23 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kei Endo's work include Liver Disease Diagnosis and Treatment (18 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and Cardiovascular Health and Disease Prevention (13 papers). Kei Endo is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and Cardiovascular Health and Disease Prevention (13 papers). Kei Endo collaborates with scholars based in Japan, China and United States. Kei Endo's co-authors include Atsuhito Saiki, Masahiro Ohira, Tomokazu Oyama, Yoh Miyashita, Kohji Shirai, Noriko Ban, Takashi Yamaguchi, Hidetoshi Kawana, Daiji Nagayama and Takeyoshi Murano and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and European Heart Journal.

In The Last Decade

Kei Endo

78 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kei Endo Japan	24	653	417	324	252	239	84	1.4k
William G. McMaster United States	12	374 0.6×	312 0.7×	239 0.7×	144 0.6×	237 1.0×	20	1.5k
Mika Enomoto Japan	21	384 0.6×	198 0.5×	368 1.1×	274 1.1×	360 1.5×	56	1.4k
Triantafyllos Didangelos Greece	24	481 0.7×	471 1.1×	674 2.1×	339 1.3×	323 1.4×	83	1.8k
Kohji Shirai Japan	23	696 1.1×	453 1.1×	359 1.1×	194 0.8×	314 1.3×	126	1.9k
Aleksandra Klisić Montenegro	20	235 0.4×	211 0.5×	306 0.9×	319 1.3×	196 0.8×	116	1.2k
Renzo De Toni Italy	19	387 0.6×	664 1.6×	691 2.1×	268 1.1×	148 0.6×	42	1.5k
Shinji Seto Japan	24	1.0k 1.5×	229 0.5×	324 1.0×	208 0.8×	143 0.6×	76	1.8k
Friedrich Mittermayer Austria	25	651 1.0×	221 0.5×	184 0.6×	415 1.6×	674 2.8×	43	1.7k
David Mymin Canada	17	329 0.5×	510 1.2×	272 0.8×	335 1.3×	97 0.4×	41	1.4k
Zhimin Ma China	21	384 0.6×	166 0.4×	299 0.9×	702 2.8×	567 2.4×	53	1.7k

Countries citing papers authored by Kei Endo

Since Specialization

Citations

This map shows the geographic impact of Kei Endo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kei Endo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kei Endo more than expected).

Fields of papers citing papers by Kei Endo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kei Endo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kei Endo. The network helps show where Kei Endo may publish in the future.

Co-authorship network of co-authors of Kei Endo

This figure shows the co-authorship network connecting the top 25 collaborators of Kei Endo. A scholar is included among the top collaborators of Kei Endo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kei Endo. Kei Endo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuroda, Hidekatsu, Tamami Abe, Keisuke Kakisaka, et al.. (2024). Early Clinical Outcomes of Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma: A Real-World Comparison with First-Line or Later-Line Treatment. Drugs - Real World Outcomes. 11(4). 701–710. 2 indexed citations

Endo, Kei, Keisuke Kakisaka, Tamami Abe, et al.. (2024). Positive impact of obesity on the prognosis of liver cirrhosis. Journal of Gastroenterology and Hepatology. 39(8). 1663–1672. 2 indexed citations

Kakisaka, Keisuke, Takuya Watanabe, Hiroaki Abe, et al.. (2024). Low liver reserve is a risk factor for acute pancreatitis in patients with acute liver failure. Hepatology Research. 55(1). 130–137. 1 indexed citations

Sugimoto, Katsutoshi, Kento Imajo, Hidekatsu Kuroda, et al.. (2024). Microwave ablation vs. single-needle radiofrequency ablation for the treatment of HCC up to 4 cm: A randomized-controlled trial. JHEP Reports. 7(1). 101269–101269. 4 indexed citations

Abe, Hiroaki, Kei Endo, Hidekatsu Kuroda, et al.. (2024). Immune checkpoint inhibitor-associated colitis in unresectable hepatocellular carcinoma: two cases of early onset after treatment with durvalumab plus tremelimumab. Clinical Journal of Gastroenterology. 17(2). 307–310. 1 indexed citations

Endo, Kei, et al.. (2023). Annual changes in grip strength and skeletal muscle mass in chronic liver disease: observational study. Scientific Reports. 13(1). 1648–1648. 3 indexed citations

Kakisaka, Keisuke, Hidekatsu Kuroda, Tamami Abe, et al.. (2023). Coincidental items in the definition of metabolic dysfunction‐associated fatty liver are useful in identifying patients having significant fibrosis with fatty liver. Hepatology Research. 53(9). 857–865. 2 indexed citations

Yoshida, Yuichi, Akiko Suzuki, Tamami Abe, et al.. (2023). Seroprevalence and incidence of hepatitis E virus infection in the general population of Iwate prefecture, Japan: A retrospective cohort study. Hepatology Research. 54(1). 24–31. 4 indexed citations

Yamaguchi, Fumihiro, et al.. (2023). Antimicrobial Stewardship Program for Patients in the Hematological Department Receiving Carbapenem Therapy: A Single-Center and Interrupted Time Series Analysis. Antibiotics. 12(2). 302–302. 1 indexed citations

10.

Endo, Kei, Hidekatsu Kuroda, Takayoshi Oikawa, et al.. (2022). Immune Checkpoint Inhibitor-Related Pneumonia in Unresectable Hepatocellular Carcinoma: Two Fatal Cases under Atezolizumab plus Bevacizumab. Liver Cancer. 11(6). 572–575. 1 indexed citations

11.

Endo, Kei, et al.. (2020). Calf and arm circumference as simple markers for screening sarcopenia in patients with chronic liver disease. Hepatology Research. 51(2). 176–189. 26 indexed citations

12.

Endo, Kei, et al.. (2020). Sustained virologic response by direct‐acting antivirals suppresses skeletal muscle loss in hepatitis C virus infection. Journal of Gastroenterology and Hepatology. 35(9). 1602–1609. 11 indexed citations

13.

Abe, Tamami, Yudai Fujiwara, Takuya Okamoto, et al.. (2019). Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma. World Journal of Gastroenterology. 25(19). 2365–2372. 24 indexed citations

14.

Suzuki, Kazuyuki, Keisuke Kakisaka, Kei Endo, et al.. (2013). Serum free fatty acid concentration as a surrogate marker for serum carnitine status in patients with liver cirrhosis. Kanzo. 54(11). 796–797. 1 indexed citations

15.

Shirai, Kohji, Atsuhito Saiki, Kei Endo, et al.. (2013). Evaluation of Blood Pressure Control using a New Arterial Stiffness Parameter, Cardio-ankle Vascular Index (CAVI). Current Hypertension Reviews. 9(1). 66–75. 43 indexed citations

16.

Endo, Kei, Atsuhito Saiki, Takashi Yamaguchi, et al.. (2013). Probucol Suppresses Initiation of Chronic Hemodialysis Therapy and Renal Dysfunction-Related Death in Diabetic Nephropathy Patients: Sakura Study. Journal of Atherosclerosis and Thrombosis. 20(5). 494–502. 18 indexed citations

17.

Chiba, Toshimi, Kunihiko Sato, Yosuke Toya, et al.. (2011). Serial Changes in Cytokine Expression in Irritable Bowel Syndrome Patients Following Treatment with Calcium Polycarbophil. Hepatogastroenterology. 58(110-111). 1527–30. 3 indexed citations

18.

Miyashita, Yoh, Kei Endo, Atsuhito Saiki, et al.. (2010). Effect of Ezetimibe Monotherapy on Lipid Metabolism and Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Type 2 Diabetic Patients. Journal of Atherosclerosis and Thrombosis. 17(10). 1070–1076. 33 indexed citations

19.

Saiki, Atsuhito, Masahiro Ohira, Kei Endo, et al.. (2010). Pioglitazone Decreases Plasma Angiotensin II Concentration inType 2 Diabetes. Journal of Atherosclerosis and Thrombosis. 17(6). 651–657. 7 indexed citations

20.

Saiki, Atsuhito, Kei Endo, Noriko Ban, et al.. (2009). Protective Effects of Efonidipine, a T- and L-Type Calcium Channel Blocker, on Renal Function and Arterial Stiffness in Type 2 Diabetic Patients with Hypertension and Nephropathy. Journal of Atherosclerosis and Thrombosis. 16(5). 568–575. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact